Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Endocrinology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Diabetes Mellitus, Type 1 Clinical Trials

A listing of Diabetes Mellitus, Type 1 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (128) clinical trials

To perform baseline and repeat assessments over time of the metabolic and immunologic status of individuals at risk for type 1 diabetes to characterize their risk for developing T1D and identify subjects eligible for prevention trials, describe the pathogenic evolution of T1D, and increase the understanding of the pathogenic factors ...

Phase N/A

A 32 week randomized study to demonstrate the superiority of an experimental drug vs Placebo measuring A1c,BMI, SPP, Bolus insulin dose in regards to baseline changes. This study is to evaluate the net clinical benefits of the experimental drug as an adjunct with Insulin therapy in Type 1 Diabetes patients

Phase

A 52 week phase 3, randomized, double-blind, placebo-controlled, parallel-group, efficacy, safety and tolerability trial of once daily, oral doses of an experimental drug as adjunctive to insulin therapy over in patients with Type 1 Diabetes Mellitus.

Phase

A research study is evaluating a Smartphone app for people with Type 1 or Type 2 Diabetes. This study is examining the ACCU-CHEK® Connect Diabetes Management System to learn whether this system improves treatment satisfaction in patients with type 1 and type 2 diabetes.

Phase N/A

A research study is evaluating a Smartphone app for people with Type 1 or Type 2 Diabetes.

Phase N/A

This will be a Phase 2b, multicenter, randomized, double blind, titration clinical study, evaluating the efficacy and safety in the HDV Insulin Lispro Group versus Insulin Lispro Group in patients with type 1 diabetes over a 26 week treatment period. The patients will be randomized using a centrally allocated randomization ...

Phase N/A

Primary objective: To demonstrate that morning injection of Toujeo compared to Lantus will provide better glycemic control evaluated by Continuous Glucose Monitoring (CGM) in adult patients with type 1 diabetes mellitus. Secondary objective(s): To demonstrate that treatment with Toujeo compared to Lantus will provide lower incidence rate of nocturnal symptomatic ...

Phase

Doctors in your area are evaluating the safety and effectiveness of a study medication to find out if it has the potential to maintain beta cell (insulin producing) function in the pancreas of children and young adults who have type 1 diabetes.

Phase N/A

Children and young adults who have Type 1 Diabetes are invited to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

The maximum duration for GLP1-RA patients will be approximately 29 weeks: an up to 2 week screening period, a 26 week treatment period (either randomized or uncontrolled), and a 3 or 9 day post-treatment safety followup period. Maximum duration for FRC patients will be approximately 55 weeks: an up to ...

Phase